Christine Rothe

Chief Development Officer (CDO) @Iomx Therapeutics Ag

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2023 — Present

Chief Development Officer (CDO) @Iomx Therapeutics Ag

View department →

EDUCATION

1996 — 1997

University of Regensburg

Post-doctoral Fellow, Cell Biology and Plant Physiology

1986 — 1991

University of Regensburg

Diplom, Biologie

1992 — 1996

University of Regensburg

Doktor (Ph.D.), Cell Biology and Plant Physiology

ABOUT CHRISTINE ROTHE

Research leader with more than 20 years of experience in discovery & preclinical development of therapeutic protein drug candidates (antibody and scaffolds) in various disease areas, all the way from starting a program up to IND enabling studies. Recent focus on respiratory diseases and bi- and multispecific drug candidates in immuno-oncology.Track record in target identification and evaluation, including due diligence processes Deep technical knowledge in drug discovery, display and characterization technologies as well as protein engineering of antibodies and new scaffolds. Skilled in project leadership of cross-functional technology, discovery and preclinical projects for internal and collaboration projects with academics, biotech and pharma partners. Long track record in international project and alliance management, including in- and out-licensing activities.Track record in supporting growth of companies by recruiting talents, growing teams and personnel and by supporting company structuring according to growth and strategic focus.Enthusiastic about translating cutting-edge science into drug candidates to bring promising therapies to patients.Advisor and expert for antibody-drug conjugate conference planning

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Christine Rothe — Chief Development Officer (CDO) at Iomx Therapeutics Ag in Munich, DE | Unifers